Rishi Sharma

Title: Rishi Sharma: Innovator in Dendrimer Delivery Systems

Introduction

Rishi Sharma is an accomplished inventor based in Baltimore, MD (US). He has made significant contributions to the field of dendrimer delivery systems, holding 2 patents that focus on innovative methods for drug delivery and treatment of various diseases.

Latest Patents

Sharma's latest patents include a dendrimer delivery system and methods of use thereof. This patent describes low-generation dendrimers that contain a high density of surface hydroxyl groups. Specifically, it details oligo ethylene glycol (OEG)-like dendrimers with a high number of surface functional groups at relatively low generations, such as approximately 120 hydroxyls in the third generation, with a size of just 1-2 nm. The formulations developed are suitable for topical, enteral, and parenteral delivery, targeting diseases and conditions in the eye, brain, and nervous system, particularly those associated with pathological activation of microglia and astrocytes. Another patent focuses on dendrimer compositions for use in angiography, disclosing compounds, compositions, kits, and methods for performing angiography related to ocular diseases.

Career Highlights

Rishi Sharma is affiliated with The Johns Hopkins University, where he continues to advance research in dendrimer technology. His work has the potential to revolutionize treatment methods for various medical conditions, showcasing his commitment to innovation in the healthcare sector.

Collaborations

Sharma collaborates with notable colleagues, including Kannan Rangaramanujam and Siva Pramodh Kambhampati, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Rishi Sharma's contributions to dendrimer delivery systems exemplify the impact of innovative thinking in medicine. His patents reflect a dedication to improving therapeutic methods and enhancing patient care.